Evidence map›Paper›PMID 36108087›Full record

ArticleThe British journal of surgery2022

Familial component of early-onset colorectal cancer: opportunity for prevention.

Maria Daca-Alvarez, Marc Martí, Antonino Spinelli, Noel F F C de Miranda, Claire Palles, Alfredo Vivas, Andrew Lachtford, Kevin Monahan, Marek Szczepkowski, Wieslaw Tarnowski and 24 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The British journal of surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Racial/Ethnic Disparities in Early-Onset Colorectal Cancer Outcomes.Journal of racial and ethnic health disparities · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Real-World Molecular Testing in European Early-Onset Colorectal Cancer.United European gastroenterology journal · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. A Novel DNA Variant inInternational journal of molecular sciences · 2024
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 7 countries.

Maria Daca-AlvarezDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.ORCID 0000-0001-5636-8865
Marc MartíDepartment of Surgery, Vall d'Hebron University Hospital, Barcelona, Spain.
Antonino SpinelliDivision of Colon and Rectal Surgery, Humanitas Research Hospital, Humanitas University, Rozzano, Italy.ORCID 0000-0002-1493-1768
Noel F F C de MirandaDepartment of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.
Claire PallesGastrointestinal Cancer Genetics Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Alfredo VivasDepartment of Surgery, Hospital Universitario 12 de Octubre, Madrid, Spain.
Andrew LachtfordPolyposis Registry and Family Cancer Clinic, St Mark's Hospital, London, UK.
Kevin MonahanPolyposis Registry and Family Cancer Clinic, St Mark's Hospital, London, UK.
Marek SzczepkowskiClinical Department of Colorectal, General and Oncological Surgery, Centre of Postgraduate Medical Education, Bielanski Hospital, Warsaw, Poland.
Wieslaw TarnowskiDepartment of Surgery, Centre of Postgraduate Medical Education, Orlowski Hospital, Warsaw, Poland.
Silviu-Tiberiu Makkai-PopaDepartment of Surgery, Centre Hospitalier de Luxembourg, Luxembourg, Belgium.
Rosario VidalMedical Oncology Department, Hospital Universitario de Salamanca, Salamanca, Spain.
Irene LópezDepartment of Surgery, Hospital MD Anderson, Madrid, Spain.
Elena HurtadoDepartment of Surgery, Hospital Universitario Gregorio Marañon, Madrid, Spain.
Fernando JiménezDepartment of Surgery, Hospital Galdakao-Usansolo, Vizcaya, Spain.
Marta Jiménez-ToscanoDepartment of Surgery, Hospital del Mar, Barcelona, Spain.
Edurne ÁlvaroDepartment of Surgery, Hospital Universitario Infanta Leonor, Madrid, Spain.
Gonzalo SanzDepartment of Surgery, Hospital Clínico San Carlos, Madrid, Spain.
Araceli BallesteroDepartment of Surgery, Hospital Universitario Ramon y Cajal, Madrid, Spain.
Sirio MeloneDepartment of Surgery, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
Lorena BrandárizDepartment of Surgery, Hospital Universitario General de Villalba, Madrid, Spain.
Isabel PrietoDepartment of Surgery, Hospital Universitario La Paz, Madrid, Spain.
Damián García-OlmoDepartment of Surgery, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.ORCID 0000-0002-9369-2338
Teresa OcañaDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Rebeca MoreiraDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Lorena MorenoDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Sabela CarballalDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Leticia MoreiraDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Maria PelliséDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Rogelio González-SarmientoMolecular Medicine Unit, Department of Medicine, Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-SACYL-CSIC, Salamanca, Spain.
Andreana N HolowatyjDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
José PereaMolecular Medicine Unit, Department of Medicine, Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-SACYL-CSIC, Salamanca, Spain.ORCID 0000-0001-5522-8844
Francesc BalaguerDepartment of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
GEOCODE and SECOC consortia
Hospital Clínic de Barcelona · ESUniversidad de Salamanca · ESCentre Hospitalier de Luxembourg · LUComplejo Hospitalario de Salamanca · ESGrochowski Hospital · PLHospital Clínico San Carlos · ESHospital de Galdakao · ESHospital Del Mar · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario 12 De Octubre · ESHospital Universitario Fundación Alcorcón · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario Infanta Leonor · ESHospital Universitario La Paz · ESHospital Universitario Ramón y Cajal · ESHumanitas University · ITLeiden University · NLMD Anderson Cancer Center Madrid · ESSt Mark's Hospital · GBUniversity of Birmingham · GB

Funding

Building Interdisciplinary Research Careers in Women's HealthK12HD043483 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARTMANN, KATHERINE E, MAJOR, AMY S · 2002 to 2023
$10.3M
NICHD NIH HHS K12 HD043483
6 · The paper itself

Abstract

backgroundIndividuals with a non-syndromic family history of colorectal cancer are known to have an increased risk. There is an opportunity to prevent early-onset colorectal cancer (age less than 50 years) (EOCRC) in this population. The aim was to explore the proportion of EOCRC that is preventable due to family history of colorectal cancer.

methodsThis was a retrospective multicentre European study of patients with non-hereditary EOCRC. The impact of the European Society of Gastrointestinal Endoscopy (ESGE), U.S. Multi-Society Task Force (USMSTF), and National Comprehensive Cancer Network (NCCN) guidelines on prevention and early diagnosis was compared. Colorectal cancer was defined as potentially preventable if surveillance colonoscopy would have been performed at least 5 years before the age of diagnosis of colorectal cancer, and diagnosed early if colonoscopy was undertaken between 1 and 4 years before the diagnosis.

resultsSome 903 patients with EOCRC were included. Criteria for familial colorectal cancer risk in ESGE, USMSTF, and NCCN guidelines were met in 6.3, 9.4, and 30.4 per cent of patients respectively. Based on ESGE, USMSTF, and NCCN guidelines, colorectal cancer could potentially have been prevented in 41, 55, and 30.3 per cent of patients, and diagnosed earlier in 11, 14, and 21.1 per cent respectively. In ESGE guidelines, if surveillance had started 10 years before the youngest relative, there would be a significant increase in prevention (41 versus 55 per cent; P = 0.010).

conclusionESGE, USMSTF, and NCCN criteria for familial colorectal cancer were met in 6.3, 9.4, and 30.4 per cent of patients with EOCRC respectively. In these patients, early detection and/or prevention could be achieved in 52, 70, and 51.4 per cent respectively. Early and accurate identification of familial colorectal cancer risk and increase in the uptake of early colonoscopy are key to decreasing familial EOCRC.

Indexed as

Colorectal NeoplasmsColonoscopyEndoscopy, GastrointestinalHumansMiddle Aged

Identifiers

PMID36108087
PMCPMC11004945
OpenAlexW4296026864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.